Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer’s disease: A systematic review and meta-analysis

Background: Currently, there are many different drugs to improve Alzheimer’s disease (AD) from different pathways. As a supplement and alternative medicine, traditional Chinese medicine (TCM) targets multiple pathways which may be different from classical Western medicine, which may be orchestrated...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xin-Yuan Du, Yu-Shuang Cao, Juan Yang, Li-Chen Guo, Tong Zhang, Qing Yuan, Xi Chen, Li-min Hu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-08-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	β-asarone Alzheimer’s disease preclinical evidence mechanisms meta-analysis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2022.956746/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!